Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:48 PM
Ignite Modification Date:
2025-12-24 @ 1:48 PM
NCT ID:
NCT07064395
Eligibility Criteria:
Inclusion Criteria:
* \>=18 years of age
* Stage Ib to IIIb primary lung cancer diagnosis
* \>=2 months after completion of primary therapy, patient can continue to be on maintenance/immunotherapy
* ECOG performance status is 0 or 1
* Experience problematic sleep (scores of \>=8 on the Insomnia Severity Index)
* Able to understand, speak, and read English
* Sighted and mentally competent to consent
Exclusion Criteria:
* Pregnant women
* Have metastatic cancer
* on oxygen therapy
* Current diagnosis of seasonal affective disorder or substance abuse
* Engage in shift work or travel across \>3 time zones within 2 weeks prior to the study
* Are currently being treated for sleep apnea, restless legs syndrome, or narcolepsy
* Take prescribed sedative hypnotics or antipsychotics
* Have eye conditions (glaucoma or retinal disease), problem triggered by bright light (e.g., migraine), or take photosensitizing medications (e.g., some porphyrin drugs, antipsychotics, antiarrhythmic agents)
* Participants with an Insomnia Severity Index \<8
* Participants with cognitive impairment (sores of \<3 mini-cog test)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07064395
Study Brief:
Protocol Section:
NCT07064395